FBXO7 (F-box only protein 7) is a substrate recognition component of the SCF (Skp1-Cul1-F-box) ubiquitin ligase complex. It plays critical roles in mitochondrial quality control, mitophagy, and neuronal survival. Pathogenic variants in FBXO7 cause autosomal recessive Parkinson's disease (PD).
¶ Gene and Protein
- Gene: FBXO7 (FBX07)
- Chromosomal Location: 22q12.3
- Protein: 524 amino acids
- Molecular Weight: ~57 kDa
- Aliases: FBX7, SCFPARKIN
FBXO7 contains multiple functional domains:
- F-box domain: Binds Skp1 for SCF complex assembly
- Ubl domain: Ubiquitin-like domain for substrate recognition
- Proline-rich region: Protein-protein interactions
- Nuclear localization signals
FBXO7 is essential for Parkin-independent mitophagy:
- Recruits ULK1 complex to damaged mitochondria
- Interacts with mitophagy receptors
- Promotes mitochondrial clearance
Although FBXO7 functions independently of PINK1/Parkin:
- Coordinates with PINK1/Parkin pathway
- Compensatory mitophagy when Parkin is absent
- Shared substrates may exist
Pathogenic variants cause PARK15 (pseudobulbar affect):
- c.1062C>A (p.Tyr354)*: Truncating mutation
- c.1483G>A (p.Glu495Lys): Missense
- c.422G>A (p.Arg141His): Missense
- Early-onset parkinsonism
- Bradykinesia
- Rigidity
- Tremor (less common)
- Neuropsychiatric features
- Cognitive decline
- Nigral degeneration
- Tau pathology
- Lewy bodies (variable)
- FBXO7 inclusions
FBXO7 targets multiple proteins:
| Substrate |
Function |
Disease Relevance |
| Mitochondrial proteins |
Quality control |
Mitophagy |
| Cyclin E |
Cell cycle |
Neurogenesis |
| BIN1 |
Cytoskeleton |
Synaptic function |
| VDAC |
Mitochondria |
Energy metabolism |
- mTORC1: FBXO7 negatively regulates mTOR
- NF-κB: Modulates inflammatory response
- Wnt: Regulates neurodevelopment
FBXO7-based therapies for PD:
- Gene therapy: Restore FBXO7 function
- Small molecules: Enhance mitophagy
- Protein-protein interaction blockers: Modulate interactions
- SCF FBXO7 inhibitors
- Mitophagy enhancers
- Neuroprotective agents
FBXO7 may play roles in AD pathogenesis:
- Mitochondrial dysfunction in AD neurons
- Amyloid-beta toxicity response
- Tau pathology interaction
- Synaptic protein degradation
- Motor neuron survival
- Mitochondrial quality control
- Protein aggregation
¶ FBXO7 and Synaptic Function
FBXO7 regulates synaptic vesicle proteins:
- SV2C interaction
- Synaptic vesicle cycling
- Neurotransmitter release
- PSD-95 regulation
- Dendritic spine maintenance
- Synaptic plasticity
- Substantia nigra: High expression
- Cortex: Moderate expression
- Hippocampus: Variable
- Cerebellum: Low
- Neurons: Primary expression
- Astrocytes: Lower levels
- Microglia: Inducible
- Kinases targeting FBXO7
- Regulation by stress
- Disease-associated changes
- Self-ubiquitination
- Deubiquitination by USP enzymes
- Stability regulation
- Knockout mice
- Transgenic models
- Zebrafish models
- Invertebrate models
- Patient-derived neurons
- iPSC models
- Knockdown/overexpression
- CSF FBXO7 levels
- Blood-brain barrier penetration
- Disease progression correlation
| Method |
Application |
| Co-IP |
Complex identification |
| Y2H |
Binary interactions |
| Mass spec |
Global interactome |
| BioID |
Proximity labeling |
- FBXO7 substrate complete mapping
- Therapeutic window for modulation
- Biomarker validation
- Gene therapy approaches